Cameron A.Reese


San Diego + 1.858.314.1192

Cameron Reese is an experienced corporate lawyer with a practice focused on mergers and acquisitions and venture capital transactions. Cameron regularly represents private equity funds, emerging companies, venture capital firms, institutional investors, and corporate acquirors in structuring and negotiating a wide range of domestic and cross-border transactions.

Cameron also represents private equity funds in connection with acquisitions and divestitures and provides counsel for many of their portfolio companies. He has experience with leveraged buyout transactions, minority investments and spin-out transactions, and has led transactions on behalf of private equity funds in a number of industry sectors, including health care, life sciences, and technology. The private equity funds with which Cameron has worked include The Riverside Company, Resilience Capital Partners, and Morgenthaler Partners.

Additionally, Cameron has an active emerging companies practice representing both technology and life science companies throughout their entire life cycle, including providing counsel and advise with respect to corporate formation, preferred stock and convertible note financing transactions, corporate governance, strategic relationships, equity incentive arrangements, and mergers and acquisitions. He also advises a number of venture capital and strategic corporate investors in connection with preferred stock financing and joint venture transactions.


  • Baird Capital sells portfolio company Vitalyst to Alithya Group, Inc.Jones Day represented Baird Capital in connection with the sale of its portfolio company Vitalyst, LLC to Alithya Group, Inc.
  • Riverside portfolio company acquires AptoJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Buildout, Inc. of Apto, a premier provider of CRM and deal management software for commercial real estate (CRE) brokers.
  • Riverside portfolio company acquires Signal VineJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Modern Campus of Signal Vine, the higher education industry’s most impactful two-way text messaging platform.
  • Dorilton Capital sells portfolio company to Specialty Welding and Turnarounds, LLCJones Day represented Dorilton Capital in connection with the sale of portfolio company Midwest Cooling Tower Services, a leading provider of mission-critical cooling tower solutions, including inspection, maintenance and repair, specialty distribution, and rental, to Specialty Welding and Turnarounds, LLC.
  • Qubiqle (d/b/a Plate IQ) raises $160 million from FTV CapitalJones Day advised Qubiqle (d/b/a Plate IQ) in the sale of a majority equity stake to FTV Capital for $160 million.
  • Pattern secures $225 million growth equity investment led by Knox LaneJones Day represented Pattern Inc., a Utah based e-commerce accelerator that helps brands optimize sales on marketplaces like Amazon, Walmart, Target, eBay and Google, in connection with a $225 million Series B Preferred Stock financing transaction, led by Knox Lane.
  • Riverside portfolio companies acquire Intarome Fragrance CorporationJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio companies Premier Specialties, Inc. and Fragrance Solutions Corporation of Intarome Fragrance Corporation, creating a disruptive new fragrance house in the middle-market founded upon decades of experience from three separate well-respected companies.
  • Entravision Communications acquires MediaDonutsJones Day advised Entravision Communications Corporation in its acquisition of MediaDonuts, a digital marketing performance and branding company with operations across seven countries in the Asia-Pacific region.
  • Entravision Communications acquires majority stake in RedmasJones Day represented Entravision Communications Corporation (NYSE: EVC) in the acquisition of a 51% interest in Redmas owned by the Cisneros Interactive Group.
  • GIC participates in $500 million Series G financing round of AffirmJones Day advised GIC, as co-lead investor, in connection with the $500 million Series G round of financing of Affirm.
  • Celularity sold UltraMIST® Ultrasound Therapy wound care assets to SANUWAVE Health, Inc.Jones Day advised Celularity Inc., a New Jersey based venture-backed biotechnology company, in the sale of its UltraMIST® Ultrasound Healing Therapy wound care assets to SANUWAVE Health, Inc. (OTCQB: SNWV).
  • Riverside sells interest in Health and Safety Institute to Waud Capital PartnersJones Day represented The Riverside Company in connection with the sale of its interest in the Health & Safety Institute (“HSI”) to Waud Capital Partners.
  • Stedical Scientific acquires PermeaDerm, Inc.Jones Day advised Stedical Scientific in its acquisition of PermeaDerm, Inc.
  • Health & Safety Institute acquires EMS Safety ServicesJones Day represented The Riverside Company in connection with the add-on acquisition and related financing of EMS Safety Services, Inc., a provider of first aid and CPR training solutions, by portfolio company Health & Safety Institute, a provider of comprehensive health and safety training courses.
  • Riverside invests in Woon-TechJones Day represented The Riverside Company in connection with its investment in and related financing of Woon-Tech, an add-on for its Cardinal platform.
  • Minted raises $208 million in Series E roundJones Day advised Minted, the leading independent design company that brings unique, best-selling design to market at scale, in connection with its $208 million Series E financing from Permira and funds and accounts advised by T. Rowe Price Associates, Inc.
  • Sempra Energy unit PXiSE Energy completes equity financing with Mitsui & Co.Jones Day advised Sempra Energy in connection with the issuance by its subsidiary, PXiSE Energy Solutions, LLC, of up to a 20 percent equity investment to Mitsui & Co., Ltd., as well as the negotiation and entering in of a strategic collaboration agreement for the development and sale of PXiSE's technology.
  • Cibus Global raises $70 million in Series C roundJones Day represented Cibus Global, Ltd., a developer of advanced plant breeding, in connection with its issuance of $70 million of Series C Convertible Preferred Stock in a private placement.
  • Entravision Communications acquires SmadexJones Day advised Entravision Communications Corporation in its acquisition of Smadex, a digital advertising technology company headquartered in Barcelona, Spain.
  • Celularity raises capital in Series B roundJones Day represented Celularity Inc., a biotechnology company that sources and develops transformative therapies derived from the placenta, in connection with its Series B Preferred Stock financing.